Edwards Lifesciences
575 hedge funds and large institutions have $13B invested in Edwards Lifesciences in 2015 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 205 increasing their positions, 218 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% less repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 218
6.63% less ownership
Funds ownership: 515.66% → 509.03% (-6.6%)
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
Holders
575
Holding in Top 10
14
Calls
$40.1M
Puts
$31.9M
Top Buyers
| 1 | +$117M | |
| 2 | +$113M | |
| 3 | +$78.8M | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.8M |
Top Sellers
| 1 | -$693M | |
| 2 | -$286M | |
| 3 | -$120M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$74.8M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$36.7M |